end
sever
patient
diagnos
pneumonia
unknown
caus
epidemiolog
associ
seafood
market
alongsid
spring
festiv
exodu
outbreak
seem
unavoid
condit
attract
attent
chines
center
diseas
control
prevent
cdc
immedi
launch
emerg
respons
world
health
organ
also
respond
promptli
declar
outbreak
public
health
emerg
intern
concern
pheic
caus
agent
unidentifi
pneumonia
confirm
novel
coronaviru
sequenc
aetiolog
investig
sever
independ
laboratori
china
follow
isol
new
coronaviru
found
distinct
middl
east
respiratori
syndrom
coronaviru
merscov
sever
acut
respiratori
syndrom
coronaviru
sarscov
coronavirus
singlestrand
rna
virus
belong
famili
coronavirida
caus
variou
diseas
enter
respiratori
hepat
neurolog
symptom
coronaviru
offici
renam
sever
acut
respiratori
syndrom
coronaviru
intern
committe
taxonomi
virus
diseas
caus
name
coronaviru
diseas
covid
quickli
becom
tremend
concern
worldwid
signific
outbreak
mani
region
china
well
global
expans
includ
asia
europ
north
america
south
america
africa
oceania
diseas
potenti
zoonot
estim
mortal
rate
persontoperson
transmiss
may
occur
contact
respiratori
transmiss
possibl
faecalor
rout
current
number
confirm
infect
increas
daili
definit
treatment
pneumonia
although
potenti
drug
investig
last
two
decad
outbreak
coronavirus
intermitt
worldwid
public
health
emerg
remind
us
coronavirus
still
sever
global
health
threat
ignor
accord
latest
research
use
inform
control
diseas
urgent
requir
highli
essenti
nm
observ
electron
microscopi
viral
particl
envelop
contain
singlestrand
positivesens
rna
genom
kb
structur
tail
interact
nucleoprotein
coronavirus
similar
organis
express
genom
genom
size
coronavirus
largest
among
rna
virus
sixteen
nonstructur
protein
encod
open
read
frame
orf
follow
nucleocapsid
n
spike
envelop
e
membran
structur
protein
encod
orf
envelop
includ
three
protein
protein
bind
nucleocapsid
enhanc
viral
assembl
bud
e
protein
involv
viral
morphogenesi
releas
pathogenesi
protein
contribut
homotrimer
spike
recognis
cell
receptor
thu
help
viru
invad
target
cell
sinc
outbreak
sar
mer
possibl
coronaviru
transmiss
anim
human
proven
coronavirus
ubiquit
pathogen
natur
human
anim
usual
caus
gastrointestin
respiratori
infect
sometim
involv
import
organ
liver
kidney
heart
brain
sensit
ultraviolet
ray
heat
lipid
solvent
ether
ethanol
chlorinecontain
disinfect
peracet
acid
chloroform
effect
inactiv
viru
coronavirus
compris
largest
group
belong
nidoviral
order
contain
famili
coronavirida
arterivirida
ronivirida
famili
coronavirida
compos
larg
singlestrand
positivesens
rna
virus
isol
sever
speci
previous
known
induc
common
cold
diarrhoeal
ill
human
subfamili
coronavirina
one
two
subfamili
coronavirida
famili
subfamili
torovirina
subfamili
coronavirina
subdivid
four
group
name
alpha
beta
gamma
delta
coronavirus
virus
initi
classifi
group
accord
serolog
label
phylogenet
cluster
alpha
beta
coronaviru
interest
human
clinic
virologist
base
epidemiolog
data
six
coronavirus
proven
caus
human
respiratori
diseas
lead
mild
upper
respiratori
diseas
rare
bring
sever
diseas
human
ii
sarscov
merscov
attack
lower
respiratori
tract
induc
sever
respiratori
syndrom
sequenc
analysi
show
typic
genom
structur
coronavirus
belong
cluster
betacoronavirus
includ
sarscov
merscov
form
clade
within
subgenu
sarbecoviru
orthocoronavirina
subfamili
seventh
member
famili
coronavirus
infect
human
far
evolutionari
model
phylogenet
analysi
deserv
attent
help
estim
genet
variabl
evolutionari
rate
turn
provid
import
implic
diseas
progress
drug
trial
vaccin
develop
zhou
et
al
report
fulllength
viral
genom
sequenc
patient
earli
outbreak
almost
ident
share
sequenc
similar
sarscov
addit
ident
wholegenom
level
bat
coronaviru
wu
et
al
almost
simultan
independ
discov
novel
rna
viru
famili
coronavirida
phylogenet
analysi
complet
viral
genom
reveal
coronaviru
close
relat
nucleotid
similar
group
sarslik
coronavirus
previous
sampl
bat
china
benvenuto
et
al
built
phylogenet
tree
includ
wholegenom
sequenc
highli
similar
avail
wholegenom
sequenc
genbank
phylogenet
tree
show
cluster
bat
sarslik
coronaviru
sequenc
isol
whilst
fast
unconstrain
bayesian
approxim
fubar
analysi
reveal
mutat
spike
glycoprotein
nucleocapsid
protein
therefor
probabl
transmit
bat
host
gain
abil
infect
human
ramaiah
et
al
specul
novel
viru
close
relat
bat
coronaviru
remind
us
novel
strain
might
evolv
bat
coronaviru
accumul
favour
genet
alter
human
infect
epitop
structur
protein
differenti
recognis
hladr
allel
suggest
subunit
vaccin
includ
eight
immunodomin
hladr
epitop
might
induc
effect
antivir
immun
respons
variou
popul
paraskevi
et
al
found
close
resembl
bat
coronaviru
sequenc
throughout
genom
similar
latter
provid
exact
variant
caus
outbreak
human
hypothesi
origin
bat
possibl
xu
et
al
also
report
share
sarssarslik
coronavirus
common
ancestor
relat
bat
coronaviru
conclud
sarscov
protein
share
almost
ident
threedimension
structur
receptorbind
domain
rbd
thu
maintain
similar
van
der
waal
electrostat
properti
interact
interfac
human
angiotensinconvert
enzym
molecul
despit
sequenc
divers
although
mani
scientist
believ
bat
intermedi
host
speci
bat
live
tropic
subtrop
rain
forest
cave
far
human
popul
thu
probabl
bat
transmit
viru
directli
human
unlik
gener
known
bat
may
spread
virus
intermedi
host
wild
anim
livestock
virus
transmit
human
ji
et
al
carri
comprehens
sequenc
analysi
comparison
conjunct
rel
synonym
codon
usag
bia
among
differ
anim
speci
base
sequenc
result
suggest
appear
recombin
viru
bat
coronaviru
coronaviru
unknown
origin
consid
snake
probabl
wildlif
anim
reservoir
conclus
controversi
guo
et
al
introduc
vhp
viru
host
predict
predict
potenti
host
virus
deep
learn
algorithm
predict
bat
coronavirus
assign
similar
infect
pattern
result
illustr
bat
mink
might
two
candid
reservoir
lam
et
al
identifi
pangolinassoci
coronavirus
belong
two
sublineag
coronavirus
includ
one
close
relat
rbd
metagenom
sequenc
henc
pangolin
consid
possibl
intermedi
host
remov
market
prevent
zoonot
transmiss
februari
case
confirm
histori
close
contact
epidem
area
confirm
patient
major
initi
symptom
includ
fever
high
fever
occur
within
sever
day
allevi
routin
antiinfect
drug
well
cough
headach
muscl
pain
fatigu
clinic
symptom
observ
lower
frequenc
includ
elev
troponin
level
diarrhoea
myalgia
myocard
emphasis
asymptomat
person
infect
therefor
pre
enc
asymptomat
carrier
requir
due
attent
one
studi
nearli
patient
appear
comorbid
regard
dysfunct
organ
primarili
renal
impair
patient
underli
cardiovascular
diseas
often
demonstr
comorbid
heart
failur
patient
gradual
develop
initi
symptom
cardiovascular
system
digest
system
nervou
system
increas
difficulti
diagnosi
studi
median
interv
start
initi
symptom
signific
symptom
aggrav
dyspnoea
appear
acut
respiratori
distress
syndrom
ard
day
rang
day
consist
previou
report
accord
newli
releas
pneumon
diagnosi
treatment
plan
novel
coronaviru
infect
sever
patient
often
dyspnoea
andor
hypoxaemia
week
onset
ill
seriou
case
quickli
progress
ard
septic
shock
irreform
metabol
acidosi
coagulopathi
multipl
organ
failur
nearli
patient
normal
decreas
white
blood
cell
count
lymphocytopenia
lung
involv
present
case
chest
comput
tomographi
ct
imag
show
lesion
multipl
lung
lobe
dens
groundglass
opac
coexist
consolid
shadow
cordlik
shadow
observ
sinc
respiratori
support
administ
patient
oxygen
satur
maintain
indic
puls
oximetri
monitor
report
sever
critic
ill
patient
moder
low
fever
even
without
obviou
fever
mild
patient
show
low
fever
mild
fatigu
pneumonia
judg
current
case
patient
good
prognosi
poor
elderli
chronic
underli
diseas
symptom
children
rel
mild
regard
current
situat
sourc
infect
mainli
infect
patient
possibl
asymptomat
infect
ignor
respiratori
droplet
close
contact
key
rout
transmiss
possibl
aerosol
transmiss
rel
close
environ
longtim
exposur
high
concentr
aerosol
also
exist
still
requir
scientif
evid
recent
rna
detect
faec
confirm
patient
pneumonia
indic
like
transmit
faecalor
rout
zhang
et
al
found
cell
receptor
highli
express
type
ii
alveolar
epitheli
cell
oesophag
epithelium
stratifi
epitheli
cell
even
absorpt
intestin
epitheli
cell
ileum
colon
bioinformat
analysi
base
singlecel
transcriptom
suggest
digest
tract
may
serv
infect
pathway
spread
infect
viru
complex
problem
requir
cooper
multipl
perspect
includ
medicin
biolog
fluid
mechan
give
complet
answer
mild
patient
may
posit
sign
whilst
sever
patient
may
short
breath
moist
rale
lung
weaken
breath
sound
dull
percuss
enhanc
weaken
vocal
fremitu
palpat
suspect
confirm
case
undergo
chest
radiographi
earli
possibl
chest
ct
scan
necessari
earli
phase
diseas
chest
imag
show
interstiti
chang
multipl
small
plaqu
especi
lung
peripheri
chang
deterior
bilater
mainli
distribut
middl
outer
zone
lung
multipl
infiltr
shadow
andor
groundglass
opac
patient
may
singl
lobe
multipl
lobe
involv
condit
improv
fibrou
stripe
may
appear
convers
lung
consolid
may
occur
sever
case
pleural
effus
rare
seen
earli
stage
white
blood
cell
count
normal
decreas
decreas
lymphocyt
count
absolut
lymphocyt
count
l
tcell
count
significantli
decreas
requir
extrem
attent
gener
recommend
recheck
routin
blood
chang
day
patient
muscl
enzym
liver
enzym
myohaemoglobin
level
increas
otherwis
troponin
increas
critic
patient
patient
display
elev
erythrocyt
sediment
rate
esr
creactiv
protein
crp
level
normal
procalcitonin
level
sever
case
show
progress
decreas
blood
lymphocyt
count
high
ddimer
level
inflammatori
factor
often
increas
sever
critic
patient
sampl
suspect
patient
collect
upper
respiratori
tract
nasopharyng
oropharyng
lower
respiratori
tract
expector
sputum
endotrach
aspir
bronchoalveolar
lavag
blood
faec
diagnos
rtpcr
two
sequenc
region
n
design
base
first
public
access
sequenc
genbank
select
primer
probe
design
highli
conserv
amongst
sarbecovirus
n
gene
assay
time
sensit
gene
assay
detect
posit
clinic
specimen
exist
pcr
method
good
specif
low
sensit
mean
neg
test
result
exclud
presenc
moreov
laboratori
sampl
contamin
caus
lack
control
lead
falseposit
result
addit
rtpcr
test
may
fals
neg
due
insuffici
viral
materi
oper
error
patient
neg
rtpcr
result
may
present
posit
chest
ct
find
mean
pcr
result
assist
clinic
diagnosi
evalu
possibl
diseas
confirm
rule
individu
high
clinic
suspicion
neg
rtpcr
screen
combin
ct
scan
repeat
swab
test
may
help
sherlock
techniqu
crisprbas
sherlock
specif
highsensit
enzymat
report
unlock
techniqu
allow
portabl
multiplex
ultrasensit
detect
rna
dna
clinic
relev
sampl
sherlock
assay
set
recombinasemedi
polymeras
preamplif
dna
rna
subsequ
detect
via
colorimetr
readout
fluoresc
provid
result
h
setup
time
min
base
rna
sequenc
novel
coronaviru
research
care
design
two
guid
rna
one
recognis
gene
new
coronaviru
recognis
gene
maximis
accuraci
detect
scientist
select
sequenc
specif
new
coronaviru
way
interfer
respiratori
viru
genom
also
minimis
theoret
long
rna
correspond
new
coronaviru
sampl
guid
rna
accur
recognis
activ
protein
bind
interest
enzym
activ
indiscrimin
intens
cut
rna
molecul
encount
way
confirm
whether
molecul
cut
detect
presenc
new
coronaviru
origin
sampl
consist
detect
target
sequenc
rang
copi
per
microlitr
input
use
synthet
viru
rna
fragment
test
read
use
dipstick
h
without
requir
elabor
instrument
still
need
confirm
patient
sampl
ren
et
al
sequenc
phylogenet
analysi
reveal
belong
betacoronavirus
nucleotid
ident
sarscov
ident
merscov
mean
closer
sarscov
merscov
importantli
homolog
model
reveal
rbd
structur
similar
sarscov
previou
report
interact
respons
sarscov
enter
human
cell
dong
et
al
compar
structur
similar
protein
variou
virus
specul
could
like
use
receptor
sarscov
zhou
et
al
conduct
viru
infect
studi
use
hela
cell
without
protein
obtain
human
anim
found
could
invad
proteinexpress
cell
except
mous
cell
short
use
entri
receptor
cell
cell
without
like
bind
receptor
human
like
sarscov
dimitrov
report
sarscov
infect
human
host
cell
basic
interact
glycoprotein
receptor
human
cell
although
sequenc
littl
differ
sarscov
function
import
orf
major
structur
protein
especi
spike
protein
well
describ
origin
ident
protein
two
region
stronger
affin
rbd
region
interact
similar
sarscov
viru
may
also
engag
rbd
bind
order
enter
human
host
cell
sinc
mani
residu
replac
differ
interact
host
cell
exist
wrapp
et
al
determin
cryogen
electron
microscopi
cryoem
structur
protein
structur
present
fig
structur
use
calcul
reconstruct
protein
fig
show
side
top
view
prefus
structur
protein
singl
receptorbind
domain
rbd
conform
two
rbd
protom
shown
either
purpl
red
rbd
protom
shown
green
result
suggest
bind
protein
ectodomain
nm
affin
approxim
higher
sarscov
result
surpris
howev
sarscov
attempt
invad
host
cell
simpl
interact
protein
pathway
cytokin
involv
chemokin
cc
motif
ligand
import
cytokin
signal
pathway
small
cc
chemokin
attract
memori
lymphocyt
monocyt
basophil
receptor
involv
inflammatori
reaction
therefor
associ
lung
inflammatori
disord
refer
previou
report
patient
infect
sarscov
pulmonari
fibrosi
due
cheung
et
al
observ
express
sarscov
patient
found
express
upregul
sera
patient
determin
relationship
signal
pathway
chen
et
al
suggest
interact
protein
sarscov
human
cell
fig
infect
lung
epitheli
cell
induc
casein
kinas
ii
ck
ii
abl
phosphoryl
involv
activ
ck
ii
phosphoryl
sarscov
bind
receptor
caus
conform
chang
also
activ
downstream
signal
transduct
pathway
includ
chang
lead
activ
upregul
also
particip
intracellular
signal
pathway
activ
interact
upstream
factor
ra
protein
kinas
c
final
elev
level
protein
sera
sarscovinfect
patient
account
develop
lung
fibrosi
similar
sarscov
similar
give
doctor
scientist
clue
look
target
drug
although
coronavirus
subject
extens
mutat
key
protein
particularli
replicationrel
enzym
highli
conserv
drug
target
conserv
proteas
usual
abl
block
replic
prolifer
viru
exhibit
broad
spectrum
specif
inhibitor
key
proteas
involv
viral
replic
prolifer
effect
way
kill
virus
candid
compound
includ
rna
proteas
membran
protein
spike
glycoprotein
polymeras
viral
envelop
act
directli
viru
well
target
host
receptor
proteas
viru
entri
endocytosi
recent
scientist
screen
four
smallmolecul
drug
prulifloxacin
tegobuvir
nelfinavir
bictegravir
strong
bind
affin
main
proteas
sarscov
first
case
pneumonia
usa
experienc
signific
improv
clinic
symptom
receiv
intraven
iv
infus
remdesivir
seventh
day
hospitalis
remdesivir
novel
nucleotid
analogu
prodrug
develop
inhibit
virus
inhibit
rnadepend
rna
polymeras
rdrp
origin
use
treat
ebola
although
effect
amazingli
effect
sar
mer
addit
unabl
infect
cell
without
bind
common
receptor
coronaviru
apn
etc
replac
four
five
import
interfac
amino
acid
residu
protein
maintain
core
structur
interact
perfectli
human
molecul
studi
show
drug
expect
use
treat
subunit
sarscov
spike
protein
play
key
role
mediat
fusion
viru
host
cell
host
cell
entri
heptapeptid
repeat
heptapeptid
repeat
interact
form
sixhelix
bundl
make
viru
cell
membran
tightli
bound
varieti
effect
fusion
inhibitor
sarscov
merscov
develop
use
peptid
research
found
region
could
also
interact
form
design
pancoronaviru
fusion
inhibitor
denot
significantli
inhibit
pseudoviru
infect
dosedepend
manner
present
differ
institut
organis
china
issu
sever
guidelin
diagnosi
treatment
novel
coronaviru
pneumonia
none
recommend
specif
drug
accord
latest
treatment
protocol
pilot
version
issu
nation
health
commiss
china
antivir
therapi
tri
interferon
lopinavirritonavir
chloroquin
phosphat
umifenovir
potenti
effect
drug
describ
remdesivir
nucleosid
analogu
antivir
activ
develop
gilead
scienc
antirna
viru
activ
confirm
ebola
viru
marburg
viru
nipa
viru
hendra
viru
furthermor
remdesivir
exhibit
prevent
therapeut
effect
merscov
sarscov
vitro
remdesivir
observ
abil
reduc
merscov
replic
improv
pulmonari
function
reduc
pulmonari
lesion
cell
mous
model
report
vero
cell
model
remdesivir
inhibit
infect
viru
ec
halfmaxim
effect
concentr
select
index
sinc
merscov
possess
similar
coronaviru
structur
remdesivir
great
potenti
report
previous
first
case
new
coronaviru
pneumonia
treat
usa
receiv
support
treatment
nausea
vomit
symptom
initi
stage
admiss
whilst
patient
symptom
improv
significantli
receiv
iv
inject
remdesivir
day
howev
remdesivir
approv
countri
safeti
effect
must
confirm
thu
two
randomis
control
doubleblind
phase
iii
trial
initi
februari
clinicaltrialsgov
id
ribavirin
broadspectrum
antivir
nucleosid
analogu
use
treatment
hepat
c
viru
respiratori
syncyti
viru
antivir
mechan
involv
interact
pleas
cite
articl
kang
april
viru
rdrp
inhibit
rna
synthesi
shown
vitro
experi
ribavirin
inhibit
replic
merscov
dosag
produc
signific
effect
within
rang
typic
human
therapi
simultan
use
interferon
reduc
dose
ribavirin
primat
model
clinic
symptom
mer
could
improv
combin
ribavirin
type
interferon
howev
side
effect
ribavirin
anaemia
limit
widespread
use
addit
two
metaanalys
sar
mer
case
studi
demonstr
limit
efficaci
treat
patient
coronaviru
respiratori
syndrom
therefor
studi
need
determin
whether
ribavirin
effect
treat
novel
coronaviru
pneumonia
covid
ribavirin
interferon
still
clinic
trial
chines
clinic
trial
registri
id
lopinavirritonavir
kaletra
aluvia
proteas
inhibitor
use
combin
therapi
human
immunodefici
virou
hiv
lopinavir
inhibit
cleavag
gagpol
protein
whilst
ritonavir
inhibit
cleavag
gagpol
protein
precursor
lopinavir
metabol
increas
concentr
lopinavir
shown
lopinavirritonavir
could
inhibit
replic
merscov
sarscov
vitro
primat
model
anim
treat
lopinavirritonavir
mer
better
prognosi
untreat
anim
noncrit
patient
south
korea
receiv
lopinavirritonavir
kaletra
abbvi
eighth
day
admiss
clinic
symptom
improv
coronaviru
load
began
decreas
undetect
anim
model
suggest
type
ii
transmembran
serin
proteas
play
import
role
coronaviru
transmiss
activ
protein
highli
pathogen
human
coronaviru
bind
receptor
enter
host
cell
thu
inhibitor
also
consid
drug
treatment
novel
coronaviru
pneumonia
interferon
ifn
type
glycoprotein
trigger
antivir
immun
respons
patient
infect
mer
anim
model
ifn
inhibit
replic
sarscov
merscov
addit
combin
therapi
ifn
antivir
drug
use
treat
sar
mer
patient
show
synergist
effect
chloroquin
also
strong
antivir
effect
sarscovinfect
cell
interfer
virusreceptor
bind
termin
glycosyl
vitro
chloroquin
enhanc
effect
antivir
drug
due
similar
rbd
structur
sarscov
screen
antisarscov
antibodi
facilit
rapid
develop
monoclon
antibodi
vaccin
tian
et
al
report
sarscovspecif
human
monoclon
antibodi
could
effect
bind
rbd
potenti
use
alon
combin
neutralis
antibodi
prevent
treatment
infect
howev
dose
need
determin
appli
monoclon
antibodi
use
convalesc
plasma
treat
critic
ill
patient
includ
latest
chines
treatment
protocol
pilot
version
one
metaanalysi
show
glucocorticoid
reduc
risk
ard
howev
differ
studi
suggest
glucocorticoid
slow
viral
clearanc
clinic
data
still
need
demonstr
valu
glucocorticoid
studi
shown
similar
sarscov
protein
rbd
human
one
reason
infect
human
use
cell
experi
zhou
et
al
report
receptor
could
bind
receptor
civet
bat
pig
human
origin
infect
cell
without
therefor
applic
ace
inhibitor
acei
angiotensin
ii
receptor
type
inhibitor
condit
close
monitor
blood
pressur
like
reduc
damag
patient
infect
xuebij
tradit
chines
medicin
inject
commonli
use
treat
inflamm
sever
case
randomis
control
trial
show
basi
western
medicin
treatment
xuebij
inject
could
significantli
reduc
fatal
rate
communityacquir
pneumonia
reliabl
evid
need
potenti
chines
medicin
travel
screen
way
limit
spread
follow
recent
emerg
aim
curtail
geograph
spread
infect
travel
symptom
screen
depend
natur
histori
infect
individu
infect
like
show
detect
symptom
increas
time
sinc
exposur
howev
travel
screen
also
limit
gostic
et
al
perform
test
estim
effect
travel
screen
found
within
narrow
rang
test
travel
screen
outcom
sensit
short
mean
incub
period
howev
longer
incub
period
larger
proport
depart
travel
exhibit
symptom
long
incub
period
still
feel
healthi
enough
travel
realis
expos
simultan
difficult
detect
folk
method
express
ad
sesam
oil
nostril
prevent
spread
find
theoret
reason
support
method
prevent
viral
infect
fan
et
al
discuss
perspect
colloid
interfac
scienc
sesam
oil
low
surfac
tension
incompat
water
investig
epidemiolog
featur
found
low
intermolecular
attract
adjac
two
sesam
oil
molecul
pure
sesam
oil
good
wettabl
could
readili
wet
surfac
variou
solid
aqueou
phase
view
featur
sesam
oil
might
prevent
spread
unfortun
mechan
method
remain
uncertain
approv
verifi
experiment
clinic
studi
futur
scientist
need
pay
scientif
attent
potenti
use
clue
folk
medicin
method
tradit
chines
medicin
herb
use
thousand
year
glycyrrhizin
tradit
chines
medicin
suggest
promis
treat
sar
consid
effect
valuabl
owe
avail
low
toxic
search
activ
compound
chines
herbal
medicin
prevent
could
pleas
cite
articl
kang
potenti
strategi
chen
du
use
molecular
dock
find
natur
compound
propos
five
candid
includ
scutellarin
baicalin
hesperetin
nicotianamin
glycyrrhizin
potenti
compound
target
receptor
exert
antivir
effect
prevent
infect
drive
china
urgent
public
health
action
well
intern
concern
summaris
recent
progress
hope
provid
potenti
intervent
spread
fast
increas
number
infect
patient
nationwid
global
futur
develop
diseas
unclear
public
pay
attent
viru
sinc
may
contagi
